Background: Lung transplantation is the only therapeutic option for patients with terminal lung disease, including cystic fibrosis (CF). Unfortunately, primary graft dysfunction (PGD), first cause of death in perioperative period, associated lower survival rates. We hypothesized that alveolar donor graft, after cold ischemia and inflammation, a critical component PGD pathophysiology recipients....